The medical imaging community is part of a growing movement toward delivery of personalized medicine, and technological advances for precision diagnoses and treatments are getting high visibility at this year’s SPIE Medical Imaging symposium.
Medical imaging technologies can provide detailed and accurate guidance for surgeons, help clinicians visualize diseased and injured tissue, predict a patient’s response to drug and radiation therapy, and create customized treatment plans based on a precise diagnosis.
SPIE Medical Imaging, 27 February through 3 March in San Diego, CA (USA), will emphasize precision medicine as an overlying theme with nearly 70 papers on disease diagnosis, prevention, and treatments that take into account individual variability in a patient’s genes, environment, and lifestyle.
Advances in precision medicine save lives and improve outcomes by enabling faster and more accurate diagnosis for diseases such as cancer, lung disease, coronary artery calcifications, and other health issues, according to the White House website on the Precision Medicine Initiative.
The papers on precision medicine will be presented across nine conferences during the weeklong symposium and be among more than 1000 papers that will cover everything from the physics of medical imaging to digital pathology to robotic interventions.
SPIE Medical Imaging also includes a keynote talk in each of the nine conferences, 12 courses, two poster sessions, several special events, and a plenary talk by Edward F. Jackson, professor and chair of medical physics at the University of Wisconsin-Madison School of Medicine and Public Health (USA). Jackson will discuss the evolution of medical imaging, from qualitative to quantitative approaches.
SPIE Vice President Maryellen Giger (right) of University of Chicago will be one of five panelists at a session 1 March to discuss radiologic tasks that could be advanced through a Grand Challenge similar to the LUNGx Challenge held during the 2015 SPIE Medical Imaging symposium.
Other panelists who will explore current imaging challenges that are worthy of becoming the subject of a future computer-aided diagnosis (CAD) Grand Challenge are Ronald M. Summers of the National Institutes of Health (USA); Joel H. Saltz of Stony Brook University (USA); Fabrice Meriaudeau from University de Bourgogne (France); and Hugo Aerts of the Dana-Farber Cancer Institute (USA). Samuel G. Armato, III, of University of Chicago, will moderate the panel.
|Chairs for SPIE Medical Imaging 2016 are SPIE member Steven C. Horii of University of Pennsylvania Health System (USA) (right) and Berkman Sahiner from the US Food and Drug Administration (far right).
More information: spie.org/MI.